Lisa Barons Pensabene is active in all areas of the firm’s patent litigation practice, focusing primarily on larger-scale litigation in the chemical, biological and pharmaceutical areas. Some of the technologies she has worked with include diabetes medicines, cardiovascular medicines, cold medicines, glaucoma medicines, pain medicines, herpes medicines, laser eye surgery apparatus, agricultural chemicals, polyester fibres for tyre and industrial use, magnetic recording particles, petroleum additives, carpet yarn, semiconductor chips and processing, charged coupled devices and recycled plastic processing. She has represented clients such as Daiichi Sankyo, AstraZeneca and Novartis.
Ms Pensabene has served as lead counsel in various pharmaceutical patent litigations, through all phases of litigation, including argument to the Federal Circuit.
Ms Pensabene is the chair of the firm’s Professional Development Committee. Her pro bono work has included child protection litigation and artists’ contract by negotiation.
Ms Pensabene’s recognitions include Practical Law Company as an up-and-coming figure on the patent litigation scene, with a particular focus on the pharmaceutical, biotech and chemical sectors. She also received recognition in Super Lawyers: New York Metro Edition.
Ms Pensabene is admitted to the Bars of the states of New York and Delaware; the US Court of Appeals for the Federal Circuit; and the US District Court for the District of Delaware. She received her JD, magna cum laude, Order of the Coif, from Georgetown University and her BS in biology from Pennsylvania State University.
Her recent article “Patent Pitfalls and Opportunities for Foreign Companies Operating in the US” was published in China Legal Review, September 2010.
1290 Avenue of the Americas
New York NY
The legality of reverse payment settlements in Paragraph IV disputes
‘Pay-for-delay’ agreements between innovator and generic manufacturers have been the subject of much controversy. Several cases have raised questions over the legality of these payments